Clene (CLNN) Competitors $3.00 -0.02 (-0.66%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$3.03 +0.03 (+0.97%) As of 04/17/2025 05:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLNN vs. BHST, OPTN, TIL, COYA, ORMP, IMUX, CLYM, CRVO, GALT, and ATOSShould you be buying Clene stock or one of its competitors? The main competitors of Clene include BioHarvest Sciences (BHST), OptiNose (OPTN), Instil Bio (TIL), Coya Therapeutics (COYA), Oramed Pharmaceuticals (ORMP), Immunic (IMUX), Climb Bio (CLYM), CervoMed (CRVO), Galectin Therapeutics (GALT), and Atossa Therapeutics (ATOS). These companies are all part of the "pharmaceutical products" industry. Clene vs. BioHarvest Sciences OptiNose Instil Bio Coya Therapeutics Oramed Pharmaceuticals Immunic Climb Bio CervoMed Galectin Therapeutics Atossa Therapeutics Clene (NASDAQ:CLNN) and BioHarvest Sciences (NASDAQ:BHST) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, community ranking, institutional ownership, earnings, profitability and risk. Which has preferable earnings and valuation, CLNN or BHST? BioHarvest Sciences has higher revenue and earnings than Clene. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Clene, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClene$342K75.40-$49.50M-$5.75-0.52BioHarvest Sciences$25.19M3.68-$12.56M-$0.72-7.85 Do institutionals & insiders believe in CLNN or BHST? 23.3% of Clene shares are held by institutional investors. 25.1% of Clene shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media prefer CLNN or BHST? In the previous week, Clene had 2 more articles in the media than BioHarvest Sciences. MarketBeat recorded 2 mentions for Clene and 0 mentions for BioHarvest Sciences. BioHarvest Sciences' average media sentiment score of 1.32 beat Clene's score of -0.50 indicating that BioHarvest Sciences is being referred to more favorably in the news media. Company Overall Sentiment Clene Negative BioHarvest Sciences Positive Which has more volatility and risk, CLNN or BHST? Clene has a beta of 0.46, meaning that its share price is 54% less volatile than the S&P 500. Comparatively, BioHarvest Sciences has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Is CLNN or BHST more profitable? BioHarvest Sciences has a net margin of -76.65% compared to Clene's net margin of -8,556.77%. BioHarvest Sciences' return on equity of 0.00% beat Clene's return on equity.Company Net Margins Return on Equity Return on Assets Clene-8,556.77% -1,106.30% -85.11% BioHarvest Sciences -76.65%N/A -85.16% Does the MarketBeat Community believe in CLNN or BHST? Clene received 78 more outperform votes than BioHarvest Sciences when rated by MarketBeat users. However, 100.00% of users gave BioHarvest Sciences an outperform vote while only 81.00% of users gave Clene an outperform vote. CompanyUnderperformOutperformCleneOutperform Votes8181.00% Underperform Votes1919.00%BioHarvest SciencesOutperform Votes3100.00% Underperform VotesNo Votes Do analysts prefer CLNN or BHST? Clene presently has a consensus price target of $55.25, indicating a potential upside of 1,741.67%. BioHarvest Sciences has a consensus price target of $13.00, indicating a potential upside of 130.09%. Given Clene's stronger consensus rating and higher probable upside, equities research analysts clearly believe Clene is more favorable than BioHarvest Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clene 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20BioHarvest Sciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryClene beats BioHarvest Sciences on 11 of the 19 factors compared between the two stocks. Get Clene News Delivered to You Automatically Sign up to receive the latest news and ratings for CLNN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLNN vs. The Competition Export to ExcelMetricClenePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.79M$6.46B$5.32B$7.35BDividend YieldN/A3.21%5.47%4.34%P/E Ratio-0.576.9521.9417.82Price / Sales75.40231.01380.9497.72Price / CashN/A65.6738.3134.64Price / Book1.445.936.453.98Net Income-$49.50M$143.22M$3.22B$247.81M7 Day Performance-0.99%4.28%5.85%3.19%1 Month Performance-29.74%-13.11%-9.58%-7.70%1 Year Performance-57.04%-8.51%11.85%1.49% Clene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLNNClene2.6652 of 5 stars$3.00-0.7%$55.25+1,741.7%-57.0%$25.79M$342,000.00-0.57100Short Interest ↑BHSTBioHarvest SciencesN/A$5.60+1.1%$13.00+132.1%N/A$91.98M$25.19M-4.48N/APositive NewsOPTNOptiNose3.1952 of 5 stars$9.10flat$9.00-1.1%-31.6%$91.66M$78.23M-2.17190Short Interest ↓Positive NewsHigh Trading VolumeTILInstil Bio2.0803 of 5 stars$13.88-5.0%$114.00+721.3%+45.2%$90.58MN/A-1.20410COYACoya Therapeutics1.8822 of 5 stars$5.39-1.1%$17.00+215.4%-34.3%$90.15M$3.55M-8.296Positive NewsGap DownORMPOramed Pharmaceuticals1.46 of 5 stars$2.10flatN/A-5.3%$85.79M$1.34M19.0910Positive NewsGap UpIMUXImmunic3.0762 of 5 stars$0.94-5.2%$13.20+1,299.5%-16.9%$85.03MN/A-0.7770Analyst ForecastAnalyst RevisionNews CoverageCLYMClimb Bio2.4315 of 5 stars$1.26+7.7%$10.00+693.7%N/A$85.02MN/A-0.599CRVOCervoMed3.4318 of 5 stars$9.76-11.9%$27.50+181.8%-59.2%$84.94M$7.14M-4.814Short Interest ↓Gap UpGALTGalectin Therapeutics1.3403 of 5 stars$1.33+0.4%$11.00+730.2%-59.1%$83.71MN/A-1.829ATOSAtossa Therapeutics1.8236 of 5 stars$0.65+7.8%$7.00+980.7%-54.5%$83.66MN/A-2.948Negative News Related Companies and Tools Related Companies BHST Competitors OPTN Competitors TIL Competitors COYA Competitors ORMP Competitors IMUX Competitors CLYM Competitors CRVO Competitors GALT Competitors ATOS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLNN) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLNN Stock Free CLNN Stock Alerts